URL copied to clipboard

Trending News

Nephro Care India Lists with Strong 90% Premium, opened at ₹171

Nephro Care India's shares opened at ₹171 on NSE SME, a 90% premium over the IPO price, reflecting significant investor enthusiasm due to the strong IPO reception.
Nephro Care India Lists with Strong 90% Premium, opened at ₹171

Nephro Care India’s shares debuted impressively on the NSE SME, opening at ₹171, which is a 90% premium over the IPO price of ₹90. This strong opening reflects significant investor enthusiasm following the IPO’s robust reception.

Nephro Care India’s IPO garnered substantial demand, being oversubscribed 715.78 times overall. Breakdown: Retail Investors at 634.12 times, QIBs at 245.14 times, and NIIs reaching an exceptional 1,787.19 times subscription rate, indicating broad and deep market interest.

Nephro Care India Limited, established in 2014 in Kolkata by Dr. Pratim Sengupta, specializes in renal care, offering dialysis and a broad range of medical services. The company operates a dialysis unit, plans to expand a hospital into a 100-bed multi-specialty facility, and provides comprehensive healthcare services including home dialysis.

Nephro Care India Ltd aims to use IPO funds and internal accruals to establish the “Vivacity Multi Specialty Hospital” in Kolkata, enhancing regional healthcare with a 100-bed facility and specialised services.

Loading
Read More News
शीर्ष प्रदर्शन करने वाले: Vedanta और 9 अन्य स्टॉक्स ने इस सप्ताह शानदार प्रदर्शन किया!

शीर्ष प्रदर्शन करने वाले: Vedanta और 9 अन्य स्टॉक्स ने इस सप्ताह शानदार प्रदर्शन किया!

दिसंबर 2024 के शीर्ष स्टॉक्स को जानें, जिसमें उच्च प्रदर्शन करने वाले शेयरों, प्रभावी निवेश रणनीतियों, और आपके निवेश

Purple United Sales IPO तीसरे दिन 148.90x सब्सक्रिप्शन के साथ बढ़ा – पूरी जानकारी यहां देखें

Purple United Sales IPO ने तीसरे दिन 148.90x विशाल सब्सक्रिप्शन के साथ समाप्त – पूरी जानकारी प्राप्त करें!

Purple United Sales IPO ने तीसरे दिन 148.90x की प्रभावशाली सब्सक्रिप्शन प्राप्त की, जो मजबूत मांग, सकारात्मक बाजार भावना, और